Literature DB >> 20552630

Sinus arrest due to sertraline.

Gonenc Kocabay1, Mustafa Yildiz, Nilufer Eksi Duran, Mehmet Ozkan.   

Abstract

Sertraline is a selective serotonin reuptake inhibitor with established safety for the treatment of depression. Among the common adverse effects associated with sertraline are nausea, insomnia, diarrhea, somnolence, and dizziness. Cardiac arrest had not been reported in the literature, although tachycardia was frequently seen. In this case report, a patient was presented who had adverse reactions such as nausea, dizziness, insomnia under citalopram treatment, and after his drug was changed to sertraline, developed sinus arrest on the fourth day of treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20552630      PMCID: PMC6653064          DOI: 10.1002/clc.20647

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  3 in total

1.  Evidence for cardiotoxicity associated with sertraline in rats.

Authors:  Sinem Ilgin; Volkan Kilic; Merve Baysal; Gozde Aydogan-Kilic; Seyda Ucarcan; Begum Dermenci; Ozlem Atli
Journal:  Toxicol Res (Camb)       Date:  2018-04-06       Impact factor: 3.524

Review 2.  Risks of Digestive System Side-Effects of Selective Serotonin Reuptake Inhibitors in Patients with Depression: A Network Meta-Analysis.

Authors:  Zhuoyue Wang; Hui Li; Yimin Kang; Yanlong Liu; Ligang Shan; Fan Wang
Journal:  Ther Clin Risk Manag       Date:  2022-08-13       Impact factor: 2.755

3.  Wide spectrum of inhibitory effects of sertraline on cardiac ion channels.

Authors:  Hyang-Ae Lee; Ki-Suk Kim; Sung-Ae Hyun; Sung-Gurl Park; Sung Joon Kim
Journal:  Korean J Physiol Pharmacol       Date:  2012-10-18       Impact factor: 2.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.